Abiomed Stocks Price Today (ABMD)
2022.12.29 10:56
Abiomed, Inc. is a stand-alone medical device technology company within Johnson & Johnson’s MedTech Segment. Abiomed designs and manufactures mechanical circulatory support devices that are implantable and temporary. Danvers, Massachusetts serves as the headquarters of the business, which also has offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo.
According to Bloomberg, the company “engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.” Andrew Greenfield serves as the company’s president, while Dr. Thorsten Siess serves as the executive vice president and chief technology officer and Dr. Chuck Simonton serves as the executive vice president and chief medical officer.
Abiomed reported $1.032 billion in revenue and reported diluted earnings per share of $2.98 for the fiscal year 2022. On December 22, Johnson & Johnson completed the acquisition of Abiomed. As of the year 2022, the company had secured five FDA approvals and 1,408 patents, with 1,416 pending.
